Clinical Trial Update: 18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

View source ↗

Summary

This clinical trial update reports an ongoing prospective observational study using 18F-FAPI PET/MRI imaging in myelofibrosis, with recruitment currently open.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis

Drugs mentioned

• 18F-FAPI PET tracer (18F-labeled fibroblast activation protein inhibitor)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Myelofibrosis | Status: RECRUITING